Specialty Pharmacy

Promotion of healthy lifestyle changes are crucial among HIV-positive patients cured of hepatitis C.

Top news of the day from across the health care landscape.

Alex M. Azar II, JD, discusses problems with the Affordable Care Act and the spread of misinformation surrounding drug costs during a session at the National Association of Specialty Pharmacy Annual Meeting and Educational Conference.

Sen Bill Cassidy, MD, spoke about the need for health care reform and the value of the specialty pharmacy at this year’s National Association of Specialty Pharmacy Annual Meeting and Educational Conference.

AbbVie grants commercialization rights to Amjevita.

The award goes to the organization that has done the most to advance patient care and the practice of specialty pharmacy.

New classes of multiple sclerosis medications are improving on disease suppression.

Capturing the correct patient data can enhance current specialty pharmacy programs to drive unparalleled care.

Mice treated prophylactically were protected from developing multiple sclerosis and neurological deficits.

Top news of the day from across the health care landscape.

BAX 930 mimics a key clotting enzyme, and could one day eliminate the need for plasma infusions for hereditary thrombotic thrombocytopenic purpura.

Janssen submits new drug application for darunavir-based, once-daily, single-tablet regimen for the treatment of HIV in adults and adolescents who are 12 years of age or older.

The second half of a 2-part series on the influential women shaping the specialty pharmacy industry.

The Graham-Cassidy-Heller-Johnson healthcare reform package faces an uncertain fate after three GOP senators express opposition.

Same-day results increase the number of individuals who get tested and treated for HCV.

Novel technique provides clues to differentiate progressors from non-progressors in AMD.

Top news of the day from across the health care landscape.

Hundreds of websites selling unapproved drugs, including opioids, antibiotics, and injectable epinephrine products.

As HIV becomes a disease of older Americans, health care professionals need to monitor the age-associated comorbidities among this population.

Inhibiting cytokines could prevent disease progression among those with multiple sclerosis.

Draft guidance seeks to enhance equivalence testing for biosimilars.

The 15-page document offers guidance on statistical approaches to evaluating biosimilar similarity.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, converses about the benefits of generic drug utilization.

Sirukumab is an anti-interleukin-6 monoclonal antibody designed to block the IL-6 pathway in a different way than currently approved IL-6 inhibitors.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Results of the case could alter the future of the biosimilar marketplace.